Daniel E. Dosoretz

3.9k total citations · 1 hit paper
74 papers, 3.0k citations indexed

About

Daniel E. Dosoretz is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Daniel E. Dosoretz has authored 74 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 23 papers in Surgery and 19 papers in Oncology. Recurrent topics in Daniel E. Dosoretz's work include Prostate Cancer Treatment and Research (28 papers), Prostate Cancer Diagnosis and Treatment (24 papers) and Colorectal and Anal Carcinomas (10 papers). Daniel E. Dosoretz is often cited by papers focused on Prostate Cancer Treatment and Research (28 papers), Prostate Cancer Diagnosis and Treatment (24 papers) and Colorectal and Anal Carcinomas (10 papers). Daniel E. Dosoretz collaborates with scholars based in United States. Daniel E. Dosoretz's co-authors include Rita M. Linggood, R.O. Mirimanoff, Robert G. Ojemann, Robert L. Martuza, Peter H. Blitzer, Sharon Salenius, Michael J. Katin, William U. Shipley, C. C. Wang and James H. Rubenstein and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of neurosurgery.

In The Last Decade

Daniel E. Dosoretz

71 papers receiving 2.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Meningioma: analysis of recurrence and progression following neurosurgical resection

1985 837 citations Daniel E. Dosoretz et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Daniel E. Dosoretz	1.4k	1.3k	966	788	709	74	3.0k
Murat Beyzadeoğlu	967 0.7×	735 0.6×	544 0.6×	492 0.6×	525 0.7×	139	2.9k
R. D. T. Jenkin	1.3k 0.9×	702 0.6×	547 0.6×	1.2k 1.5×	898 1.3×	57	4.2k
Ferrat Dinçoğlan	817 0.6×	637 0.5×	497 0.5×	463 0.6×	403 0.6×	90	2.4k
Selçuk Demiral	820 0.6×	626 0.5×	481 0.5×	462 0.6×	415 0.6×	91	2.4k
Rolf‐Peter Müller	1.0k 0.7×	615 0.5×	392 0.4×	564 0.7×	779 1.1×	56	2.6k
Kevin Oh	1.2k 0.8×	735 0.6×	608 0.6×	313 0.4×	826 1.2×	90	2.7k
Bahar Dırıcan	693 0.5×	537 0.4×	409 0.4×	387 0.5×	336 0.5×	88	2.1k
Andrew J. Bishop	1.1k 0.8×	850 0.7×	297 0.3×	284 0.4×	623 0.9×	124	2.2k
Jean‐Michel Zucker	1.5k 1.1×	652 0.5×	351 0.4×	971 1.2×	775 1.1×	77	3.7k
Uğur Selek	1.0k 0.7×	758 0.6×	389 0.4×	170 0.2×	958 1.4×	144	2.5k

Countries citing papers authored by Daniel E. Dosoretz

Since Specialization

Citations

This map shows the geographic impact of Daniel E. Dosoretz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Dosoretz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Dosoretz more than expected).

Fields of papers citing papers by Daniel E. Dosoretz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Dosoretz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Dosoretz. The network helps show where Daniel E. Dosoretz may publish in the future.

Co-authorship network of co-authors of Daniel E. Dosoretz

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Dosoretz. A scholar is included among the top collaborators of Daniel E. Dosoretz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Dosoretz. Daniel E. Dosoretz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Braunstein, Lior Z., Ming‐Hui Chen, Daniel E. Dosoretz, et al.. (2015). Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk. Clinical Genitourinary Cancer. 13(6). 555–561. 4 indexed citations

Parekh, Arti, Ming‐Hui Chen, Anthony V. D’Amico, et al.. (2013). Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer. Brachytherapy. 12(5). 415–421. 4 indexed citations

Olivera, G, Weiguo Lu, X. H. Mo, et al.. (2013). In Vivo Verification as a Tool to Tailor Daily IGRT and Flag Adaptive Radiotherapy. Practical Radiation Oncology. 3(2). S2–S3. 1 indexed citations

Nanda, Akash, Ming‐Hui Chen, Brian J. Moran, et al.. (2012). Neoadjuvant Hormonal Therapy Use and the Risk of Death in Men with Prostate Cancer Treated with Brachytherapy Who Have No or at Least a Single Risk Factor for Coronary Artery Disease. European Urology. 65(1). 177–185. 22 indexed citations

Wattson, Daniel A., Ming‐Hui Chen, Judd W. Moul, et al.. (2012). The Number of High-Risk Factors and the Risk of Prostate Cancer–Specific Mortality After Brachytherapy: Implications for Treatment Selection. International Journal of Radiation Oncology*Biology*Physics. 82(5). e773–e779. 17 indexed citations

Westover, Kenneth D., Ming‐Hui Chen, Judd W. Moul, et al.. (2012). Radical prostatectomy vs radiation therapy and androgen‐suppression therapy in high‐risk prostate cancer. British Journal of Urology. 110(8). 1116–1121. 41 indexed citations

Winkfield, Karen M., Ming‐Hui Chen, Daniel E. Dosoretz, et al.. (2011). Race and Survival Following Brachytherapy-Based Treatment for Men With Localized or Locally Advanced Adenocarcinoma of the Prostate. International Journal of Radiation Oncology*Biology*Physics. 81(4). e345–e350. 9 indexed citations

Nguyen, Paul L., Ming‐Hui Chen, Joshua A. Beckman, et al.. (2011). Influence of Androgen Deprivation Therapy on All-Cause Mortality in Men With High-Risk Prostate Cancer and a History of Congestive Heart Failure or Myocardial Infarction. International Journal of Radiation Oncology*Biology*Physics. 82(4). 1411–1416. 55 indexed citations

Chen, Ming‐Hui, Yuanye Zhang, Brian J. Moran, et al.. (2011). Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 82(3). e463–e467. 23 indexed citations

10.

Chen, Ming‐Hui, Sharon Salenius, Daniel E. Dosoretz, et al.. (2010). Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy. Cancer. 116(4). 837–842. 17 indexed citations

11.

Hoffman, Karen E., Ming‐Hui Chen, Brian J. Moran, et al.. (2010). Prostate cancer‐specific mortality and the extent of therapy in healthy elderly men with high‐risk prostate cancer. Cancer. 116(11). 2590–2595. 28 indexed citations

12.

Nguyen, Paul L., Ming H. Chen, Toni K. Choueiri, et al.. (2010). Risk of All-Cause and Prostate Cancer–Specific Mortality After Brachytherapy in Men With Small Prostate Size. International Journal of Radiation Oncology*Biology*Physics. 79(5). 1318–1322. 8 indexed citations

13.

Cheung, Arthur, Ming‐Hui Chen, Brian J. Moran, et al.. (2010). The use of supplemental external beam radiotherapy in men with low-risk prostate cancer undergoing brachytherapy before and after the 1999 American Brachytherapy Society Guideline statement. Brachytherapy. 9(2). 145–150. 3 indexed citations

14.

Nanda, Akash, Ming‐Hui Chen, Brian J. Moran, et al.. (2009). Total Androgen Blockade Versus a Luteinizing Hormone–Releasing Hormone Agonist Alone in Men With High-Risk Prostate Cancer Treated With Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 76(5). 1439–1444. 9 indexed citations

15.

Nanda, Akash, Ming‐Hui Chen, Brian J. Moran, et al.. (2009). Predictors of Prostate Cancer–Specific Mortality in Elderly Men With Intermediate-Risk Prostate Cancer Treated With Brachytherapy With or Without External Beam Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 77(1). 147–152. 11 indexed citations

16.

Mantz, C.A., Daniel E. Dosoretz, James H. Rubenstein, et al.. (2004). Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysis. Brachytherapy. 3(4). 183–190. 11 indexed citations

17.

Dosoretz, Daniel E., James H. Rubenstein, Michael J. Katin, et al.. (1998). Small-Cell Lung Carcinoma. American Journal of Clinical Oncology. 21(4). 333–337. 3 indexed citations

18.

Rubenstein, James H., Daniel E. Dosoretz, Michael J. Katin, et al.. (1995). Low doses of prophylactic cranial irradiation effective in limited stage small cell carcinoma of the lung. International Journal of Radiation Oncology*Biology*Physics. 33(2). 329–337. 16 indexed citations

19.

Dosoretz, Daniel E., James H. Rubenstein, Michael J. Katin, et al.. (1993). Local control in medically inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication. International Journal of Radiation Oncology*Biology*Physics. 27(3). 507–516. 110 indexed citations

20.

Dosoretz, Daniel E., Michael J. Katin, Peter H. Blitzer, et al.. (1992). Radiation therapy in the management of medically inoperable carcinoma of the lungs: Results and implications for future treatment strategies. International Journal of Radiation Oncology*Biology*Physics. 24(1). 3–9. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact